Agfa, Quantum sign letter of internet for VAR agreement

TriMed Staff | | Health Imaging | Screening
Agfa's HealthCare business group announced today that Quantum Medical Imaging of Ronkonkoma, N.Y., has signed a letter of intent with Agfa, establishing Quantum as a value added reseller of exclusively Agfa products, systems, solutions and services in the United States. Once finalized, the agreement will allow Quantum to provide digital and analog imaging solutions to its complete dealer distribution channel and meet the needs of its customers.

The three-year, renewable agreement also will include the possible development of entirely new product packages combining complementary Agfa and Quantum technological solutions.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.